{
    "nctId": "NCT01117181",
    "title": "Apathy in Dementia Methylphenidate Trial (ADMET)",
    "symPyJSON": {
        "type": "and",
        "operands": [
            {
                "type": "and",
                "operands": [
                    {
                        "type": "variable",
                        "value": "Possible or probable Alzheimer's disease (National Institute of Neurological and Communicative Disorders and Stroke - Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria)"
                    },
                    {
                        "type": "variable",
                        "value": "Mini-Mental State Exam (MMSE) score of 10-26 inclusive"
                    },
                    {
                        "type": "variable",
                        "value": "Clinically significant apathy for at least four weeks"
                    },
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "frequency of apathy as assessed by the Neuropsychiatric Inventory (NPI) is 'Very frequently'"
                            },
                            {
                                "type": "and",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "frequency of apathy as assessed by the NPI is 'Frequently' or 'Often'"
                                    },
                                    {
                                        "type": "variable",
                                        "value": "severity of apathy as assessed by the NPI is 'Moderate' or 'Marked'"
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "type": "variable",
                        "value": "A medication for apathy is appropriate, in the opinion of the study physician"
                    },
                    {
                        "type": "variable",
                        "value": "Provision of informed consent for participation in the study by patient or surrogate (if the patient is unable to provide informed consent) and caregiver"
                    },
                    {
                        "type": "variable",
                        "value": "Availability of primary caregiver, who spends greater than ten hours a week with the patient and supervises his/her care, to accompany the patient to study visits and to participate in the study"
                    },
                    {
                        "type": "variable",
                        "value": "Sufficient fluency, of both the patient and caregiver, in written and spoken English to participate in study visits, physical exams, and outcome assessments"
                    },
                    {
                        "type": "variable",
                        "value": "No change to AD medications within the month preceding randomization, including starting, stopping, or dosage modifications"
                    },
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "and",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "Treatment with stable doses of selective serotonin reuptake inhibitor antidepressants (SSRIs)"
                                    },
                                    {
                                        "type": "variable",
                                        "value": "stable for 3 months prior to randomization"
                                    }
                                ]
                            },
                            {
                                "type": "and",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "Other psychotropics (with the exclusion of antipsychotics)"
                                    },
                                    {
                                        "type": "variable",
                                        "value": "stable for 3 months"
                                    },
                                    {
                                        "type": "variable",
                                        "value": "Steering Committee approval on a case by case basis"
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "type": "variable",
                        "value": "Must have minimum age of 18 Years"
                    }
                ]
            },
            {
                "type": "not",
                "operands": [
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Meets criteria for Major Depressive Episode, by Diagnostic Statistical Manual of Mental Disorder - IV (TR) criteria"
                            },
                            {
                                "type": "or",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "frequency of agitation/aggression as assessed by the NPI is 'Very frequently'"
                                    },
                                    {
                                        "type": "and",
                                        "operands": [
                                            {
                                                "type": "variable",
                                                "value": "frequency of agitation/aggression as assessed by the NPI is 'Frequently'"
                                            },
                                            {
                                                "type": "variable",
                                                "value": "severity of the agitation as assessed by the NPI is 'Moderate' or 'Marked'"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "type": "or",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "frequency of delusions as assessed by the NPI is 'Very frequently'"
                                    },
                                    {
                                        "type": "and",
                                        "operands": [
                                            {
                                                "type": "variable",
                                                "value": "frequency of delusions as assessed by the NPI is 'Frequently'"
                                            },
                                            {
                                                "type": "variable",
                                                "value": "severity of the delusions as assessed by the NPI is 'Moderate' or 'Marked'"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "type": "or",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "frequency of hallucinations as assessed by the NPI is 'Very frequently'"
                                    },
                                    {
                                        "type": "and",
                                        "operands": [
                                            {
                                                "type": "variable",
                                                "value": "frequency of hallucinations as assessed by the NPI is 'Frequently'"
                                            },
                                            {
                                                "type": "variable",
                                                "value": "severity of the hallucinations as assessed by the NPI is 'Moderate' or 'Marked'"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "type": "variable",
                                "value": "Treatment with psychotropic medications in the 2 weeks prior to randomization with the exception of approved treatments for dementia (ChEIs and memantine), selective serotonin reuptake inhibitor antidepressants, and trazodone (if used as an aid to facilitate sleep and not as an antidepressant)"
                            },
                            {
                                "type": "variable",
                                "value": "Treatment with methylphenidate is contraindicated in the opinion of the study physician"
                            },
                            {
                                "type": "variable",
                                "value": "Failure of treatment with methylphenidate in the past for apathy after convincing evidence of an adequate trial as judged by study physician"
                            },
                            {
                                "type": "variable",
                                "value": "Treatment with a medication that would prohibit the safe concurrent use of methylphenidate such as monoamine oxidase inhibitors and tricyclic antidepressants"
                            },
                            {
                                "type": "variable",
                                "value": "Need for acute psychiatric hospitalization or is suicidal"
                            },
                            {
                                "type": "variable",
                                "value": "Uncontrolled hypertension (medication non-compliance or past 3 months with a diastolic reading of 105 as verified by compartment pressure of the rectus sheath (CPRS))"
                            },
                            {
                                "type": "variable",
                                "value": "Symptomatic coronary artery disease deemed to be significant by study physician at the time of screening"
                            },
                            {
                                "type": "variable",
                                "value": "Lack of appetite that results in significant unintentional weight loss as determined by the study physician in the last three months"
                            },
                            {
                                "type": "variable",
                                "value": "Significant communicative impairments"
                            },
                            {
                                "type": "variable",
                                "value": "Current participation in a clinical trial or in any study that may add significant burden or affect study outcomes"
                            },
                            {
                                "type": "variable",
                                "value": "Hyperthyroidism, advanced arteriosclerosis, symptomatic cardiovascular disease, serious structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or a family history of sudden death or death related to heart problems"
                            },
                            {
                                "type": "variable",
                                "value": "Glaucoma, pheochromocytoma, or known or suspected hypersensitivity to methylphenidate or its excipients"
                            },
                            {
                                "type": "variable",
                                "value": "Central Nervous System (CNS) abnormalities (e.g., cerebral aneurysm) and/or other vascular abnormalities such as vasculitis or pre-existing stroke, motor tics or a family history or diagnosis of Tourette's syndrome, seizures (convulsions, epilepsy), or abnormal EEGs"
                            },
                            {
                                "type": "variable",
                                "value": "Any condition that, in the opinion of the study physician, makes it medically inappropriate or risky for the patient to enroll in the trial"
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "symPyExpression": "And(Symbol('A medication for apathy is appropriate, in the opinion of the study physician'), Symbol('Availability of primary caregiver, who spends greater than ten hours a week with the patient and supervises his/her care, to accompany the patient to study visits and to participate in the study'), Symbol('Clinically significant apathy for at least four weeks'), Symbol('Mini-Mental State Exam (MMSE) score of 10-26 inclusive'), Symbol('Must have minimum age of 18 Years'), Symbol('No change to AD medications within the month preceding randomization, including starting, stopping, or dosage modifications'), Symbol(\"Possible or probable Alzheimer's disease (National Institute of Neurological and Communicative Disorders and Stroke - Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria)\"), Symbol('Provision of informed consent for participation in the study by patient or surrogate (if the patient is unable to provide informed consent) and caregiver'), Symbol('Sufficient fluency, of both the patient and caregiver, in written and spoken English to participate in study visits, physical exams, and outcome assessments'), Or(Symbol(\"frequency of apathy as assessed by the Neuropsychiatric Inventory (NPI) is 'Very frequently'\"), And(Symbol(\"frequency of apathy as assessed by the NPI is 'Frequently' or 'Often'\"), Symbol(\"severity of apathy as assessed by the NPI is 'Moderate' or 'Marked'\"))), Or(And(Symbol('Treatment with stable doses of selective serotonin reuptake inhibitor antidepressants (SSRIs)'), Symbol('stable for 3 months prior to randomization')), And(Symbol('Other psychotropics (with the exclusion of antipsychotics)'), Symbol('Steering Committee approval on a case by case basis'), Symbol('stable for 3 months'))), Not(Or(Symbol('Any condition that, in the opinion of the study physician, makes it medically inappropriate or risky for the patient to enroll in the trial'), Symbol(\"Central Nervous System (CNS) abnormalities (e.g., cerebral aneurysm) and/or other vascular abnormalities such as vasculitis or pre-existing stroke, motor tics or a family history or diagnosis of Tourette's syndrome, seizures (convulsions, epilepsy), or abnormal EEGs\"), Symbol('Current participation in a clinical trial or in any study that may add significant burden or affect study outcomes'), Symbol('Failure of treatment with methylphenidate in the past for apathy after convincing evidence of an adequate trial as judged by study physician'), Symbol('Glaucoma, pheochromocytoma, or known or suspected hypersensitivity to methylphenidate or its excipients'), Symbol('Hyperthyroidism, advanced arteriosclerosis, symptomatic cardiovascular disease, serious structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or a family history of sudden death or death related to heart problems'), Symbol('Lack of appetite that results in significant unintentional weight loss as determined by the study physician in the last three months'), Symbol('Meets criteria for Major Depressive Episode, by Diagnostic Statistical Manual of Mental Disorder - IV (TR) criteria'), Symbol('Need for acute psychiatric hospitalization or is suicidal'), Symbol('Significant communicative impairments'), Symbol('Symptomatic coronary artery disease deemed to be significant by study physician at the time of screening'), Symbol('Treatment with a medication that would prohibit the safe concurrent use of methylphenidate such as monoamine oxidase inhibitors and tricyclic antidepressants'), Symbol('Treatment with methylphenidate is contraindicated in the opinion of the study physician'), Symbol('Treatment with psychotropic medications in the 2 weeks prior to randomization with the exception of approved treatments for dementia (ChEIs and memantine), selective serotonin reuptake inhibitor antidepressants, and trazodone (if used as an aid to facilitate sleep and not as an antidepressant)'), Symbol('Uncontrolled hypertension (medication non-compliance or past 3 months with a diastolic reading of 105 as verified by compartment pressure of the rectus sheath (CPRS))'), Symbol(\"frequency of agitation/aggression as assessed by the NPI is 'Very frequently'\"), Symbol(\"frequency of delusions as assessed by the NPI is 'Very frequently'\"), Symbol(\"frequency of hallucinations as assessed by the NPI is 'Very frequently'\"), And(Symbol(\"frequency of agitation/aggression as assessed by the NPI is 'Frequently'\"), Symbol(\"severity of the agitation as assessed by the NPI is 'Moderate' or 'Marked'\")), And(Symbol(\"frequency of delusions as assessed by the NPI is 'Frequently'\"), Symbol(\"severity of the delusions as assessed by the NPI is 'Moderate' or 'Marked'\")), And(Symbol(\"frequency of hallucinations as assessed by the NPI is 'Frequently'\"), Symbol(\"severity of the hallucinations as assessed by the NPI is 'Moderate' or 'Marked'\")))))"
}